Prostate News Archive
08-Nov-2007
On a Mission to End the Silence: New Organization Opens Conversation About Prostate Cancer (PR Newswire via Yahoo! Finance)
Every week, 500 Americans die of prostate cancer. Even though prostate cancer occurs more often than breast cancer, public awareness is minimal. The good news is that this is going to change. Fraternity holds event to raise awarness of prostate cancer (State Hornet)
The sounds of rap and hip-hop disseminated throughout the University Union today as Epsilon Sigma Rho, a multicultural fraternity at Sacramento State, organized a disc jockey battle to raise awareness for prostate cancer, the most common type of cancer among men. Early diagnosis of prostate cancer (News-Medical-Net)
Treating prostate cancer is a race against time. By the time the patient can feel the first symptoms, the disease has usually spread too far. Novacea: Asentar failure presents opportunities to other prostate drug developers (Pharmaceutical Business Review)
Novacea has terminated the Phase III ASCENT-2 trial evaluating Asentar in combination with Taxotere in hormone-refractory prostate cancer. The failure of Asentar provides a favorable opportunity for other prostate cancer drug developers in this area of high unmet need, but leaves prostate cancer sufferers disappointed. Experimental Drug Fights Prostate Cancer (HealthDay via Yahoo! News)
WEDNESDAY, Nov. 7 (HealthDay News) -- In mice, an investigational agent called VN/14-1 proved effective in treating human prostate cancer, say researchers at the University of Maryland in Baltimore.
Back to Prostate News Archive
